<DOC>
	<DOCNO>NCT01925625</DOCNO>
	<brief_summary>HYPOTHESIS In high risk population EarlyCDT-Lung test reduces incidence late stage tumour ; 3 / 4 / Unclassified ( U ) diagnosis compare normal clinical practice .</brief_summary>
	<brief_title>Early Cancer Detection Test - Lung Cancer Scotland</brief_title>
	<detailed_description>AIMS To assess effectiveness EarlyCDT-Lung test increase early stage lung cancer detection , thereby reduce rate late stage ( 3 / 4 / U ) presentation , compare normal clinical practice ; assess cost-effectiveness EarlyCDT-Lung test compare normal clinical practice ; assess effectiveness EarlyCDT-Lung test reduce adverse outcome include potential psychological behavioural consequence .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>1 . Participant willing able give inform consent participation study 2 . Male female age 50 year 75 year 3 . Current Exsmoker least 20 year pack history 4. Less 20 year pack history family history lung cancer 1st degree relative ( mother , father , sister , brother , child ) 5 . ECOG Status : 0 , 1 2 ( Eastern Cooperative Oncology Group ) Grade ECOG 0 Fully active , able carry predisease performance without restriction 1 Restricted physically strenuous activity ambulatory able carry work light sedentary nature , e.g. , light house work , office work 2 Ambulatory capable selfcare unable carry work activity . Up 50 % waking hour 6 . Geographical postal sector : NHS Geographical Area Eligible Postcodes Tayside DD1 DD11 , PH1PH3 , PH6PH8 , PH10 , PH11 , PH13 , PH15 &amp; PH16 Greater Glasgow &amp; Clyde G1G5 , G11 G15 , G20G22 , G3134 , G40 G46 , G51 G53 , G60G62 &amp; G64 , G66 &amp; G69 , G72 &amp; G73 , G76G78 , G81G83 PA1PA8 ( except PA6 ) , PA11PA16 &amp; PA19 1 . History cancer nonmelanomatous skin cancer , cervical cancer situ . 2 . Symptoms suggestive lung cancer within past 6 month ( haemoptysis , unintentional weight loss ( least 5 % precede 6 month ) . 3 . Patients GP considers invitation study would cause undue distress . 4 . Patients terminal disease . 5 . Patients prolong / continuous use ( &gt; 3months ) cytotoxic/ immunosuppressant drug eg : Cyclophosphamide . Monotherapy use glucocorticoids/ steroid eg prednisolone NOT exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>